This episode is sponsored by BONESUPPORT™, maker of CERAMENT® G with Gentamicin – the one and only FDA authorized, antibiotic-eluting bone void filler. For more information, visit BONESUPPORT.com.
Chris Kreulen, MD, from University of California – Davis Health is joined by Chris Murawski, MD and Paul Ryan, MD, FAAOS to discuss their ever-evolving approach to bone infection. Over the course of thirty minutes, they discuss their move towards single-stage surgeries, advancements in total ankle revisions, and their increased ability to preserve limbs. They also include their tips, tricks, and pearls for getting the most out of new technologies like CERAMENT G. Interested in staying in touch? Follow BONESUPPORT on LinkedIn.
References discussed in this episode:
- Winkler, E et al. Foot Osteomyelitis Location and Rates of Primary or Secondary Major Amputations in Patients With Diabetes. Foot & Ankle International, 107110072210885.
- Hennessy C et al. MORTALITY, RE-AMPUTATION, AND POSTOPERATIVE COMPLICATION RATES FOLLOWING 28,000 BELOW-KNEE AMPUTATIONS IN DIABETIC PATIENTS IN ENGLAND: A NATIONAL POPULATION STUDY, 2002–2022. Orthop Procs. 2025 Feb 10;107-B(SUPP_1):18-18.
- Certain L. Embracing Change: Oral Antibiotics for Diabetic Foot Osteomyelitis. Foot & Ankle International. 2025;46(10):1090-1091.
- Khakzad T et al. Cementless one-stage hip revision arthroplasty with an injectable antibiotic bone graft substitute : a pilot study. Bone Jt Open. 2025 Sep 25;6(9):1146-1155
For additional educational resources, visit AOFAS.org